These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25311071)

  • 1. Myocardial ischemic events in 'real world' patients treated with dabigatran.
    Shah R
    Am J Med; 2014 Oct; 127(10):e19. PubMed ID: 25311071
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse skin reaction caused by dabigatran.
    Cakmak MA; Sahin S; Cinar N; Karsidag S
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2595. PubMed ID: 25317789
    [No Abstract]   [Full Text] [Related]  

  • 3. Approach to the new oral anticoagulants in family practice: part 1: comparing the options.
    Douketis J; Bell AD; Eikelboom J; Liew A
    Can Fam Physician; 2014 Nov; 60(11):989-95. PubMed ID: 25392438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the efficacy and safety of new oral anticoagulant drugs in the secondary stroke prevention in patients with AF: single center experience based on 311 patients.
    Lasek-Bal A; Urbanek T; Gierek D
    Int Angiol; 2015 Dec; 34(6):552-61. PubMed ID: 25410296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions.
    Douketis J; Bell AD; Eikelboom J; Liew A
    Can Fam Physician; 2014 Nov; 60(11):997-1001. PubMed ID: 25392439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
    Graham DJ; Reichman ME; Wernecke M; Zhang R; Southworth MR; Levenson M; Sheu TC; Mott K; Goulding MR; Houstoun M; MaCurdy TE; Worrall C; Kelman JA
    Circulation; 2015 Jan; 131(2):157-64. PubMed ID: 25359164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.
    Beyer-Westendorf J; Ageno W
    Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of rivaroxaban on myocardial infarction in the ATLAS ACS 2 - TIMI 51 trial.
    Cavender MA; Gibson CM; Braunwald E; Wiviott SD; Murphy SA; Toda Kato E; Plotnikov AN; Amuchástegui M; Oude Ophuis T; van Hessen M; Mega JL
    Eur Heart J Acute Cardiovasc Care; 2015 Oct; 4(5):468-74. PubMed ID: 25318481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of Triple AXEL: trial for early anticoagulation in acute ischemic stroke patients with nonvalvular atrial fibrillation.
    Hong KS; Choi YJ; Kwon SU;
    Int J Stroke; 2015 Jan; 10(1):128-33. PubMed ID: 25346499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Edoxaban: an investigational factor xa inhibitor.
    Hughes GJ; Hilas O
    P T; 2014 Oct; 39(10):686-715. PubMed ID: 25336863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis.
    Nielsen PB; Lane DA; Rasmussen LH; Lip GY; Larsen TB
    Clin Res Cardiol; 2015 May; 104(5):418-29. PubMed ID: 25416564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apixaban use among patients with severe renal impairment.
    Deal EN; Pope H; Ross W
    Ann Pharmacother; 2014 Dec; 48(12):1667. PubMed ID: 25388542
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of bleeding complications between warfarin, dabigatran, and rivaroxaban in patients undergoing cryoballoon ablation.
    Snipelisky D; Ray JC; Ung R; Duart M; Kauffman C; Kusumoto F
    J Interv Card Electrophysiol; 2014 Dec; 41(3):231-6. PubMed ID: 25380703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of PER977 to reverse the anticoagulant effect of edoxaban.
    Ansell JE; Bakhru SH; Laulicht BE; Steiner SS; Grosso M; Brown K; Dishy V; Noveck RJ; Costin JC
    N Engl J Med; 2014 Nov; 371(22):2141-2. PubMed ID: 25371966
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk of bleeding with dabigatran in atrial fibrillation.
    Hernandez I; Baik SH; Piñera A; Zhang Y
    JAMA Intern Med; 2015 Jan; 175(1):18-24. PubMed ID: 25365537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-country comparison of rivaroxaban spontaneous adverse event reports and concomitant medicine use with the potential to increase the risk of harm.
    McDonald CJ; Kalisch Ellett LM; Barratt JD; Caughey GE
    Drug Saf; 2014 Dec; 37(12):1029-35. PubMed ID: 25361529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is concomitant aspirin helping novel oral anticoagulants? Focus on apixaban.
    DiNicolantonio JJ; Tomek A; Meier P; O'Keefe JH; D'Ascenzo F; Cerrato E; Chatterjee S; Biondi-Zoccai G
    Open Heart; 2014; 1(1):e000134. PubMed ID: 25332826
    [No Abstract]   [Full Text] [Related]  

  • 18. Acquired factor v inhibitor developing after treatment with dabigatran etexilate methanesulfonate: a case report and review of the literature.
    Sekiguchi Y; Yoshikawa H; Shimada A; Imai H; Wakabayashi M; Sugimoto K; Nakamura N; Sawada T; Ichinose T; Ozaki D; Komatsu N; Noguchi M
    Indian J Hematol Blood Transfus; 2014 Sep; 30(Suppl 1):275-9. PubMed ID: 25332596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticoagulant therapy with dabigatran in elderly patients ≥80 years of age with atrial fibrillation].
    Kono T; Ogimoto A; Aono J; Okura T; Shigematsu Y; Higaki J
    Nihon Ronen Igakkai Zasshi; 2014; 51(4):350-5. PubMed ID: 25327369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures.
    Garcia D; Alexander JH; Wallentin L; Wojdyla DM; Thomas L; Hanna M; Al-Khatib SM; Dorian P; Ansell J; Commerford P; Flaker G; Lanas F; Vinereanu D; Xavier D; Hylek EM; Held C; Verheugt FW; Granger CB; Lopes RD
    Blood; 2014 Dec; 124(25):3692-8. PubMed ID: 25320240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.